The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab ... for a variety of head and neck cancers, as well as mouth and ...

Molecular classification of tumors is likely to provide important ... “reviews”, “head-and-neck cancer”, “cervical cancer” and “prognosis”. Papers from the search were reviewed ...

Researchers have identified the molecular and cellular mechanisms that transform healthy stem cells into oral cancer at the earliest stages of the disease.

A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...

Understanding how tumors alter their metabolism to evade treatments is an increasingly important area of cancer research.

Missing weekly cisplatin cycles was associated with worse OS in patients with head and neck cancers, particularly for those with p16-negative tumors.

Turnstone, which went public via an $80 million IPO in 2023, ended September 2024 with $45.3 million to hand, which the ...

Head and neck cancers affect the mouth, throat, larynx, and more, with early detection being crucial for better survival chances. Key early symptoms include persistent sore throat, voice changes, ...

Understanding how tumors change their metabolism to resist treatments is a growing focus in cancer research. As cancer cells adapt to therapies, their metabolism often shifts, which can help them ...

Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...

20th Annual Congress in a presentation titled “Neoadjuvant Immunotherapy for Head and Neck Cancer: Low Tumor PD-L1 Expression - IT-MATTERS – RCT”. Highlights of the presentation include ...